Session Type
Meeting
Search Results for Diabetes
Abstract Number: 149
SHM Converge 2023
Background: The effects of diabetes medications on COVID-19 hospitalization outcomes have not been consistent. We sought to determine the effect of metformin, DPP-4 inhibitors (DPP-4i), and insulin on admission to the intensive care unit (ICU), need for assisted ventilation, development of renal insufficiency, and mortality, in patients admitted with COVID-19 infection after controlling for clinical […]
Abstract Number: 152
SHM Converge 2023
Background: Diabetes mellitus (DM) is a chronic disease where treatment is directed toward reducing and delaying its potentially severe short- and long-term complications. The estimated population (20-79 years old) with diabetes is 32.22 million in the United States, and 12.5% of people live with undiagnosed diabetes (Figure 1). Diabetes Mellitus is currently the most prevalent […]
Abstract Number: 156
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: It is estimated that nearly 20 million people are taking Statins (HMG-CoA Reductase Inhibitors) currently in the United States. The benefits of statins to treat and prevent cardiovascular disease are accepted universally. However, recent evidence indicates an increased risk of new onset diabetes mellitus (DM) in this population. A literature review was done to […]
Abstract Number: 164
Hospital Medicine 2020, Virtual Competition
Background: The risk for serious infections and poor treatment outcomes is reported to be higher in patients with diabetes compared to the general population. Omadacycline (OMC) is an intravenous (IV) and oral aminomethylcycline antibiotic approved in the US to treat acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) in adults. […]
Abstract Number: 165
SHM Converge 2023
Background: Approximately one-third of patients with acute ischemic stroke (AIS) develop hyperglycemia regardless of pre-existing history of diabetes [1]. Hyperglycemia is associated with increased risk of hemorrhagic transformation and can be considered as a predictor of poor functional outcome after intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) [2]. Additionally, risk of death, hemorrhagic complications, and […]
Abstract Number: 170
SHM Converge 2023
Background: Attention to the quality of glycemic management during the hospital stay, including care transitions, has grown with increasing evidence linking inpatient and post-discharge glycemic control to clinical outcomes, widespread use of glucometric benchmarking, and impending pay-for-performance measures. Clinical inertia (nonadherence to guidelines) and therapeutic inertia (failure to adjust medications as indicated) or CTI among […]
Abstract Number: 178
SHM Converge 2023
Background: Hypoglycemia is common and potentially life-threatening for diabetic patients, often iatrogenic from diabetes treatments. It is important to be able to accurately study rates of hypoglycemia when evaluating the inpatient treatment of diabetes at a systems-level. Discharge diagnosis codes show promise as a tool in the surveillance of hypoglycemic events in large administrative databases […]
Abstract Number: 178
SHM Converge 2024
Background: Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes mellitus that is increasing in frequency, and yet is preventable with adequate outpatient management. Studies have shown that children with diabetes in minority populations experience more frequent DKA admissions, possibly due to inequities in healthcare access. We examined whether disparities by race/ethnicity exist in DKA […]
Abstract Number: 182
SHM Converge 2023
Background: Recent work by the authors showed that over half of the incidences of hypoglycemia in hospitalized diabetics involved patients with CKD, and that 18% of patients with diabetes and end-stage renal disease (ESRD) had a hypoglycemic episode while hospitalized. The importance of reducing inpatient hypoglycemia is reflected in the Centers for Medicare and Medicaid […]
Abstract Number: 192
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Hyperglycemia and hyperosmolarity are frequent causes of hospitalization in patients with type II Diabetes Mellitus (T2DM). As a result, these conditions are associated with increased mortality, morbidity and increased health costs. This study examines the outcomes of patients with T2DM admitted for hyperglycemia and hyperosmolarity. Methods: Vizient database is a large administrative database and […]